GlassScriptPhysician profile
Edward Jw Shields
NPI 1952690257
$6,858.68
in general payments reported to CMS, 2019-2025
14 companies · $4,929 in 2025
The $4,929 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.91 · 2020: $26.83 · 2021: $1,274 · 2022: $155 · 2023: $126 · 2024: $255 · 2025: $4,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,830 · Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,830.00 |
| Food and Beverage | $480.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $4,830.00 | 2025 | |
| Medwest Associates | $1,200.00 | 2021 | |
| Smith+Nephew, INC. | $313.07 | 2022-2024 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Q-Fix |
| Zimmer Biomet Holdings, INC. | $189.12 | 2024-2025 | Comprehensive Shoulder System, Rosa, Tapestry |
| Stryker Corporation | $54.55 | 2021-2022 | |
| Pacira Therapeutics, INC. | $53.76 | 2020-2021 | |
| Alimera Sciences, INC. | $48.96 | 2019 | |
| Depuy Synthes Sales INC. | $43.08 | 2023-2025 | Fms, Healix Knotless Peek |
| Radius Health, INC. | $37.21 | 2019-2023 | Tymlos |
| Avanos Medical | $29.80 | 2019 | |
| Abbott Laboratories | $25.88 | 2025 | Proclaim |
| Embody, INC. | $14.94 | 2023 | |
| Ferring Pharmaceuticals INC. | $12.50 | 2020 | |
| Meditrina | $5.81 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$62,349.53 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Shields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.